(NYSE: SCL) Stepan Co's forecast annual revenue growth rate of 5.39% is forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 4.58%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 25.77%.
Stepan Co's revenue in 2025 is $2,303,837,000.On average, 3 Wall Street analysts forecast SCL's revenue for 2025 to be $53,652,303,580, with the lowest SCL revenue forecast at $51,955,877,455, and the highest SCL revenue forecast at $55,914,205,080. On average, 3 Wall Street analysts forecast SCL's revenue for 2026 to be $58,017,773,475, with the lowest SCL revenue forecast at $55,868,967,050, and the highest SCL revenue forecast at $60,777,293,305.
In 2027, SCL is forecast to generate $60,732,055,275 in revenue, with the lowest revenue forecast at $58,289,201,655 and the highest revenue forecast at $63,808,241,315.